Jeffrey Eisele - Apr 25, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Exec VP, Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Stock symbol
APLS
Transactions as of
Apr 25, 2022
Transactions value $
-$4,600
Form type
4
Date filed
12/23/2022, 03:15 PM
Previous filing
Feb 1, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Other $0 -1.25K -3.79% $0.00 31.7K Apr 25, 2022 Direct F1
transaction APLS Common Stock Tax liability -$4.6K -89 -0.28% $51.68 31.7K Dec 22, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents the cancellation of a PSU awards granted on 01/28/2021 that was originally reported in table I upon grant. The performance metrics were not met.
F2 This represents shares used to cover tax withholding on a Restricted Stock Unit release.